1651 - 1675 of 6255 Results
Title
Year
- Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials2014OPENTitle: Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trialsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 127Issue #: 6Start Page: 861End Page: 879Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-014-1256-4Citation Count: 216
- Involvement of Perineuronal and Perisynaptic Extracellular Matrix in Alzheimer's Disease Neuropathology2011OPENTitle: Involvement of Perineuronal and Perisynaptic Extracellular Matrix in Alzheimer's Disease NeuropathologyJournal Name: Brain PathologyPublisher: WileyVol: 22Issue #: 4Start Page: 547End Page: 561Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1750-3639.2011.00557.xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3639011Citation Count: 146
-
OPENTitle: Task-rest modulation of basal ganglia connectivity in mild to moderate Parkinson’s diseaseJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 9Issue #: 3Start Page: 619End Page: 638Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11682-014-9317-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4385510Citation Count: 31
- Biochemical Increase in Phosphorylated Alpha‐Synuclein Precedes Histopathology of Lewy‐Type Synucleinopathies2012OPENTitle: Biochemical Increase in Phosphorylated Alpha‐Synuclein Precedes Histopathology of Lewy‐Type SynucleinopathiesJournal Name: Brain PathologyPublisher: WileyVol: 22Issue #: 6Start Page: 745End Page: 756Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1750-3639.2012.00585.xBest OA location URL: http://doi.org/10.1111/j.1750-3639.2012.00585.xCitation Count: 66
- Critical Role of Truncated α‐Synuclein and Aggregates in Parkinson's Disease and Incidental Lewy Body Disease2012OPENTitle: Critical Role of Truncated α‐Synuclein and Aggregates in Parkinson's Disease and Incidental Lewy Body DiseaseJournal Name: Brain PathologyPublisher: WileyVol: 22Issue #: 6Start Page: 811End Page: 825Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1750-3639.2012.00597.xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5505643Citation Count: 61
-
OPENTitle: Age-related changes in glutathione and glutathione-related enzymes in rat brainJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1090Issue #: 1Start Page: 35End Page: 44Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2006.03.063Best OA location URL: http://doi.org/10.1016/j.brainres.2006.03.063Citation Count: 271
-
OPENTitle: CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1408Issue #:Start Page: 88End Page: 97Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2011.06.057Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4120020Citation Count: 74
- Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease2010OPENTitle: Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1367Issue #:Start Page: 310End Page: 318Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2010.08.099Best OA location URL: https://europepmc.org/articles/pmc3005012?pdf=renderCitation Count: 48
-
OPENTitle: Dysrhythmia of timed movements in Parkinson׳s disease and freezing of gaitJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1624Issue #:Start Page: 222End Page: 231Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2015.07.041Best OA location URL: http://doi.org/10.1016/j.brainres.2015.07.041Citation Count: 27
-
OPENTitle: Changes in attack behavior and activity in EphA5 knockout miceJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1205Issue #:Start Page: 91End Page: 99Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2008.02.047Best OA location URL: http://doi.org/10.1016/j.brainres.2008.02.047Citation Count: 22
- Allopurinol reduces levels of urate and dopamine but not dopaminergic neurons in a dual pesticide model of Parkinson׳s disease2014OPENTitle: Allopurinol reduces levels of urate and dopamine but not dopaminergic neurons in a dual pesticide model of Parkinson׳s diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1563Issue #:Start Page: 103End Page: 109Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2014.03.031Best OA location URL: https://europepmc.org/articles/pmc4146456?pdf=renderCitation Count: 17
- Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson’s Disease2017OPENTitle: Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson’s DiseaseJournal Name: Brain SciencesPublisher: MDPI AGVol: 7Issue #: 7Start Page: 74End Page: 74Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci7070074Best OA location URL: https://www.mdpi.com/2076-3425/7/7/74/pdf?version=1500945204Citation Count: 20
- Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease2008OPENTitle: Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 131Issue #: 7Start Page: 1880End Page: 1894Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awn101Best OA location URL: https://academic.oup.com/brain/article-pdf/131/7/1880/1093630/awn101.pdfCitation Count: 328
- Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease2012OPENTitle: Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 135Issue #: 11Start Page: 3355End Page: 3370Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/aws254Best OA location URL: https://academic.oup.com/brain/article-pdf/135/11/3355/759911/aws254.pdfCitation Count: 168
-
OPENTitle: Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 132Issue #: 7Start Page: 1783End Page: 1794Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awp044Best OA location URL: https://academic.oup.com/brain/article-pdf/132/7/1783/13734818/awp044.pdfCitation Count: 656
- Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesia2011OPENTitle: Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesiaJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 134Issue #: 8Start Page: 2339End Page: 2357Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awr165Best OA location URL: https://academic.oup.com/brain/article-pdf/134/8/2339/13735225/awr165.pdfCitation Count: 131
-
OPENTitle: Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 134Issue #: 8Start Page: 2358End Page: 2365Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awr139Best OA location URL: https://academic.oup.com/brain/article-pdf/134/8/2358/1015592/awr139.pdfCitation Count: 111
-
OPENTitle: Disease duration and the integrity of the nigrostriatal system in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 136Issue #: 8Start Page: 2419End Page: 2431Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awt192Best OA location URL: https://academic.oup.com/brain/article-pdf/136/8/2419/11140480/awt192.pdfCitation Count: 1156
- Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study2015OPENTitle: Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding studyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 138Issue #: 4Start Page: 963End Page: 973Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awu409Best OA location URL: https://kclpure.kcl.ac.uk/ws/files/148083964/Eltoprazine_counteracts_L_DOPA_induced_SVENNINGSSON_Publishedonline5February2015_GOLD_VoR_CC_BY_NC_.pdfCitation Count: 152
- Thalamic cholinergic innervation and postural sensory integration function in Parkinson’s disease2013OPENTitle: Thalamic cholinergic innervation and postural sensory integration function in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 136Issue #: 11Start Page: 3282End Page: 3289Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awt247Best OA location URL: https://academic.oup.com/brain/article-pdf/136/11/3282/11138755/awt247.pdfCitation Count: 173
- Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo2014OPENTitle: Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivoJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 137Issue #: 5Start Page: 1496End Page: 1513Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awu057Best OA location URL: https://academic.oup.com/brain/article-pdf/137/5/1496/11140606/awu057.pdfCitation Count: 218
-
OPENTitle: Parkinson’s disease in GTP cyclohydrolase 1 mutation carriersJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 137Issue #: 9Start Page: 2480End Page: 2492Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awu179Best OA location URL: https://academic.oup.com/brain/article-pdf/137/9/2480/13798270/awu179.pdfCitation Count: 180
- Nigral stimulation for resistant axial motor impairment in Parkinson’s disease? A randomized controlled trial2013OPENTitle: Nigral stimulation for resistant axial motor impairment in Parkinson’s disease? A randomized controlled trialJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 136Issue #: 7Start Page: 2098End Page: 2108Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awt122Best OA location URL: https://academic.oup.com/brain/article-pdf/136/7/2098/13795851/awt122.pdfCitation Count: 202
- Subthalamic stimulation modulates cortical motor network activity and synchronization in Parkinson’s disease2015OPENTitle: Subthalamic stimulation modulates cortical motor network activity and synchronization in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 138Issue #: 3Start Page: 679End Page: 693Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awu380Best OA location URL: https://academic.oup.com/brain/article-pdf/138/3/679/13799397/awu380.pdfCitation Count: 79
- Loss-of-function mutations in theATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)2016OPENTitle: Loss-of-function mutations in theATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)Journal Name: BrainPublisher: Oxford University Press (OUP)Vol: 140Issue #: 2Start Page: 287End Page: 305Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/aww307Best OA location URL: https://academic.oup.com/brain/article-pdf/140/2/287/24174630/aww307.pdfCitation Count: 152